Skip to main content

Published locations for Commentary: IL-31 inhibitor, e-cigarettes, and upadacitinib in AD, April 2023

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Commentary: IL-31 inhibitor, e-cigarettes, and upadacitinib in AD, April 2023

User login

  • Reset your password
  • /content/commentary-il-31-inhibitor-e-cigarettes-and-upadacitinib-ad-april-2023
  • /dermatology/article/262093/atopic-dermatitis/commentary-il-31-inhibitor-e-cigarettes-and